Cargando…

Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma

BACKGROUND AND AIMS: Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFNAR1) have been associated with the susceptibility to and the outcome of chronic hepatitis B virus (HBV) infection. However, the impact of these polymorphisms in the transcriptome of the HBV-associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Karamitros, Timokratis, Papatheodoridis, George, Paraskevis, Dimitrios, Hatzakis, Angelos, Mbisa, Jean L., Georgopoulou, Urania, Klenerman, Paul, Magiorkinis, Gkikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911724/
https://www.ncbi.nlm.nih.gov/pubmed/29713327
http://dx.doi.org/10.3389/fimmu.2018.00777
_version_ 1783316262198181888
author Karamitros, Timokratis
Papatheodoridis, George
Paraskevis, Dimitrios
Hatzakis, Angelos
Mbisa, Jean L.
Georgopoulou, Urania
Klenerman, Paul
Magiorkinis, Gkikas
author_facet Karamitros, Timokratis
Papatheodoridis, George
Paraskevis, Dimitrios
Hatzakis, Angelos
Mbisa, Jean L.
Georgopoulou, Urania
Klenerman, Paul
Magiorkinis, Gkikas
author_sort Karamitros, Timokratis
collection PubMed
description BACKGROUND AND AIMS: Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFNAR1) have been associated with the susceptibility to and the outcome of chronic hepatitis B virus (HBV) infection. However, the impact of these polymorphisms in the transcriptome of the HBV-associated hepatocellular carcinoma (HCC) remains largely unexplored. METHODS: Using whole-genome and exome sequencing data from The Cancer Genome Atlas project, we characterized three single-nucleotide polymorphisms (SNPs: −568G/C, −408C/T, −3C/T) and one variable number tandem repeat [VNTR: −77(GT)n] within the IFNAR1 promoter sequence in 49 HCC patients. RNAseq data from 10 genotyped HCC samples were grouped according to their −77VNTR or −3SNP genotype to evaluate the impact of these polymorphisms on the differential expression on the HCC transcriptome. RESULTS: There is a fourfold higher impact of the −77VNTR on the HCC transcriptome compared to the −3SNP (q < 0.1, p < 0.001). The expression of the primary IFNAR1 transcript is not affected by these polymorphisms but a secondary, HCC-specific transcript is expressed only in homozygous −77VNTR ≤8/≤8(GT)n samples (p < 0.05). At the same time, patients carrying at least one −77VNTR >8(GT) allele, presented a strong upregulation of the fibronectin-1 (FN-1) gene, which has been associated with the development of HCC. Gene Ontology and pathway enrichment analysis of the differentially expressed genes revealed a strong disruption of the PI3K–AKT signaling pathway, which can be partially triggered by the extracellular matrix FN-1. CONCLUSION: The IFNAR-1 promoter polymorphisms are not involved in the expression levels of the main IFNAR-1 transcript. The −77VNTR has a regulatory role on the expression of a secondary, truncated, HCC-specific transcript, which in turn coincides with disruptions in cancer-associated pathways and in FN-1 expression modifications.
format Online
Article
Text
id pubmed-5911724
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59117242018-04-30 Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma Karamitros, Timokratis Papatheodoridis, George Paraskevis, Dimitrios Hatzakis, Angelos Mbisa, Jean L. Georgopoulou, Urania Klenerman, Paul Magiorkinis, Gkikas Front Immunol Immunology BACKGROUND AND AIMS: Genetic polymorphisms within the promoter of interferon-α receptor type-1 (IFNAR1) have been associated with the susceptibility to and the outcome of chronic hepatitis B virus (HBV) infection. However, the impact of these polymorphisms in the transcriptome of the HBV-associated hepatocellular carcinoma (HCC) remains largely unexplored. METHODS: Using whole-genome and exome sequencing data from The Cancer Genome Atlas project, we characterized three single-nucleotide polymorphisms (SNPs: −568G/C, −408C/T, −3C/T) and one variable number tandem repeat [VNTR: −77(GT)n] within the IFNAR1 promoter sequence in 49 HCC patients. RNAseq data from 10 genotyped HCC samples were grouped according to their −77VNTR or −3SNP genotype to evaluate the impact of these polymorphisms on the differential expression on the HCC transcriptome. RESULTS: There is a fourfold higher impact of the −77VNTR on the HCC transcriptome compared to the −3SNP (q < 0.1, p < 0.001). The expression of the primary IFNAR1 transcript is not affected by these polymorphisms but a secondary, HCC-specific transcript is expressed only in homozygous −77VNTR ≤8/≤8(GT)n samples (p < 0.05). At the same time, patients carrying at least one −77VNTR >8(GT) allele, presented a strong upregulation of the fibronectin-1 (FN-1) gene, which has been associated with the development of HCC. Gene Ontology and pathway enrichment analysis of the differentially expressed genes revealed a strong disruption of the PI3K–AKT signaling pathway, which can be partially triggered by the extracellular matrix FN-1. CONCLUSION: The IFNAR-1 promoter polymorphisms are not involved in the expression levels of the main IFNAR-1 transcript. The −77VNTR has a regulatory role on the expression of a secondary, truncated, HCC-specific transcript, which in turn coincides with disruptions in cancer-associated pathways and in FN-1 expression modifications. Frontiers Media S.A. 2018-04-16 /pmc/articles/PMC5911724/ /pubmed/29713327 http://dx.doi.org/10.3389/fimmu.2018.00777 Text en Copyright © 2018 Karamitros, Papatheodoridis, Paraskevis, Hatzakis, Mbisa, Georgopoulou, Klenerman and Magiorkinis. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Karamitros, Timokratis
Papatheodoridis, George
Paraskevis, Dimitrios
Hatzakis, Angelos
Mbisa, Jean L.
Georgopoulou, Urania
Klenerman, Paul
Magiorkinis, Gkikas
Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma
title Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma
title_full Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma
title_fullStr Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma
title_full_unstemmed Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma
title_short Impact of Interferon-α Receptor-1 Promoter Polymorphisms on the Transcriptome of the Hepatitis B Virus-Associated Hepatocellular Carcinoma
title_sort impact of interferon-α receptor-1 promoter polymorphisms on the transcriptome of the hepatitis b virus-associated hepatocellular carcinoma
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911724/
https://www.ncbi.nlm.nih.gov/pubmed/29713327
http://dx.doi.org/10.3389/fimmu.2018.00777
work_keys_str_mv AT karamitrostimokratis impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma
AT papatheodoridisgeorge impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma
AT paraskevisdimitrios impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma
AT hatzakisangelos impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma
AT mbisajeanl impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma
AT georgopoulouurania impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma
AT klenermanpaul impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma
AT magiorkinisgkikas impactofinterferonareceptor1promoterpolymorphismsonthetranscriptomeofthehepatitisbvirusassociatedhepatocellularcarcinoma